DekaBank Deutsche Girozentrale’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,000	Closed	-$232K	–	1545
2023 Q2	$232K	Hold	5,000	–	–	﹤0.01%	1142
2023 Q1	$143K	Hold	5,000	–	–	﹤0.01%	1226
2022 Q4	$156K	Buy	+5,000	New	+$163K	﹤0.01%	1257

DekaBank Deutsche Girozentrale's DICE Position: Q3 2023 in Review

DekaBank Deutsche Girozentrale sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 5,000 shares — an estimated $232K sold.

DekaBank Deutsche Girozentrale first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $232K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

DekaBank Deutsche Girozentrale reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 5,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $232K.
DekaBank Deutsche Girozentrale first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
DekaBank Deutsche Girozentrale's DICE Therapeutics, Inc. Common Stock position peaked at $232K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2023, filed 13 Nov 2023.